Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6419
    -0.0006 (-0.10%)
     
  • OIL

    83.41
    +0.68 (+0.82%)
     
  • GOLD

    2,410.00
    +12.00 (+0.50%)
     
  • Bitcoin AUD

    100,241.44
    +1,628.74 (+1.65%)
     
  • CMC Crypto 200

    1,381.61
    +68.99 (+5.26%)
     
  • AUD/EUR

    0.6024
    -0.0007 (-0.11%)
     
  • AUD/NZD

    1.0902
    +0.0027 (+0.25%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,043.34
    -350.97 (-2.02%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,948.90
    +173.52 (+0.46%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Archelis’ exoskeleton is basically a chair you can wear

I’ve written a fair bit about exoskeletons on these pages. They’re a fascinating subset of the robotics industry designed to improve mobility and assist with manual labor that can be taxing on the body. The FX Stick is a lower tech version, lacking the sorts of battery-powered systems that drive those products.

If anything, it probably has more in common with some of the “wearable chairs” you can find around the internet. Though the product is less about grabbing a seat and your desk and more for people who work on their feet and could benefit from taking a load off from time to time.

Announced at CES this week, the FX Stick is a follow-up to the ArchelisFX system that we discussed a bit at last year’s show. It’s more flexible, 15% lighter and designed to be put on (16 seconds) and taken off (nine seconds) significantly quicker.

At ~$3,000, it’s pretty pricey. That’s significantly less than most of the powered suits out there, but my guess is that most nurses and factory workers aren’t going to shell out that much for a product like this, regardless of how much it purports to alleviate back pain (40% says the company).

I suspect employers — rather than employees — are the likely target here, especially if the company can accurately demonstrate that such a technology could help keep people on their feet longer and avoid potential medical issues.